
Free Daily Podcast Summary
by TransPerfect Life Sciences
Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
The most recent episodes — sign up to get AI-powered summaries of each one.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of Clinical Technologies at Almac Clinical Technologies, to talk about the burden clinical trial sites face when one study runs on up to 15 applications. They discuss why single sign-on and data standards have been slow to take hold, and how established providers can modernize their systems without putting live studies at risk. The conversation also covers the difference between making a process electronic and truly digitizing it, and why eCOA calls for more than an add-on to an existing eClinical offering.
Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027, to challenge some long-held assumptions in the COA space. They examine why some legacy instruments were built for a different era, what gets lost when items are stitched together from multiple measures, and whether computer adaptive testing could finally solve the patient burden problem. Kathrin also shares why cultural and regional bias in instrument design deserves more scrutiny, and where she'd point her magic wand if she could change one thing about the future of COA.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent is better perceived by patients, the fragmented technology landscape sites have to navigate, the plain-language and health-literacy challenges baked into consent forms, and the timeline and budget pressures that keep eConsent from being standard practice. They also cover why pediatric and rare disease studies could be the fastest path to wider adoption, and how reconsent, an often-overlooked, recurring part of the process, is particularly well suited to going digital.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. The two discuss why keeping a rigorous measure is often harder than building it in the first place, walk through why studies still run on out-of-date versions and translations, and reflect on what happens when one of these unvalidated instruments is used in real-world applications. Tune in to hear why the same words on a page can mean something different a decade later, and how thoughtful measurement keeps instruments rigorous, relevant, and ready for whatever comes next, AI included.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical development and where real flexibility and patient centricity live. Together, they unpack the gap between what a protocol asks for and how it gets delivered, the trouble with arbitrary First Patient In (FPI) dates and the timeline pressure that forces teams to cut corners, and the creep of unnecessary measures and patient burden that undermines data quality. They also dig into smarter, more patient-centric approaches, from item libraries and computer adaptive testing to disease-specific instrument selection, and the hidden risks of the "copy-and-paste" protocol.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, to discuss whether the field of clinical outcome assessment has started sacrificing “good for perfect.” Together, they explore the role of regulatory guidance and clinical development timelines, specifically the role of measurement science in already tight development timelines, when to modify a legacy instrument versus build something new, and why getting measurement scientists involved early is the key to a successful COA strategy.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner at Sprout Health Solutions, to discuss how pharma companies of all sizes can build a comprehensive, patient-centric evidence strategy that spans the entire drug development pathway. Together, they examine the growing role of COA and in-study interviews in regulatory decision-making, the practical barriers to earlier patient engagement. They explore how eCOA providers could add greater value by getting involved long before a pivotal trial, and a focus on why the choice of data capture modality matters far more than the industry currently recognizes.
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP of Patient-Centered Outcomes at Kielo Research, to take a behind-the-scenes look at the reality of patient-centered instrument development. They discuss diaries and quality of life tools, rare disease challenges, and proxy reporting, as well as the tradeoffs that can often occur in balancing regulatory rigor, patient burden, and realistic instrument usability. Listen in to hear why multiple instruments for the same disease can often create not only frustration for patients, but can also overburden them simultaneously. The episode will share suggestions as to how study teams can design smarter, more patient-centered measurement strategies.
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

The Long Run with Luke Timmerman
In-depth conversations with biotech leaders navigating the challenges and opportunities of advancing science for human health.

Bringing Chemistry to Life
Talks with leading chemists about their discoveries, careers, and the science shaping our world.

TED Talks Science and Medicine
Scientists, doctors, and medical researchers present groundbreaking discoveries and ideas from TED and TEDx events worldwide.

The Health Continuum
High-performing professionals learn science-based health strategies to sustain energy, focus, and resilience in demanding careers.

Real Talk, Whole Life
Cloud10

Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.

Good Life Project
Deep conversations about building a meaningful life through midlife reinventions, grounded in science and human experience.

Treated with Dr. Sara Szal
Dr. Sara Szal explores holistic health solutions through conversations with experts and patients seeking mind, body, and soul healing.

The Biohacking Standards
A deep dive into biohacking fundamentals—nutrition, movement, sleep, and mindfulness—grounded in science and holistic wellness principles.

Unbiased Science
Dr. Jess Steier and guests analyze viral health claims using scientific evidence and explain key findings for everyday conversations.

Made for Health | Peptides | Lyme | Chronic Infections | Long Covid | Insulin Resistance | Hypermobility
A physician explores science-based approaches to treating chronic conditions and restoring health.

The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from LifeSci Talks in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of LifeSci Talks as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by TransPerfect Life Sciences.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
LifeSci Talks publishes monthly. Our AI generates a summary within hours of each new episode.
LifeSci Talks covers topics including Science, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.